GENMAB A/S -SP ADR (GMAB) Stock Income Statement
NASDAQ:GMAB - Nasdaq - US3723032062 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.94B | 3.28B | 2.51B | 2.21B | 8.42B | |||
| Cost Of Goods | 324.94M | 150.07M | 34.43M | 0.00 | 0.00 | |||
| Gross Profit | 7.62B | 3.13B | 2.48B | 2.21B | 8.42B | |||
| Operating Expenses | 4.96B | 2.05B | 1.66B | 1.25B | 5.46B | |||
| Research and Development | 3.61B | 1.46B | 1.15B | 830.93M | 4.18B | |||
| Selling, General, and Administrative Expenses | 1.34B | 571.93M | 495.45M | 401.91M | 1.27B | |||
| Operating Income | 2.66B | 1.08B | 810.67M | 960.59M | 2.95B | |||
| Interest Income/Expense | 704.34M | 374.94M | 48.14M | 103.30M | 965.00M | |||
| Non Recurring Items | N/A | -57.28M | 0.00 | -5.79M | N/A | |||
| Income Before Taxes | 3.18B | 1.40B | 858.81M | 1.06B | 3.92B | |||
| Income Tax | 799.99M | 201.11M | 195.77M | 227.46M | 961.00M | |||
| Net Income | 2.38B | 1.20B | 663.04M | 830.63M | 2.96B | |||
| EBITDA | 2.74B | 1.14B | 855.62M | 1.02B | 3.20B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 3.83 | 1.92 | 1.04 | 1.31 | 4.65 | |||
| Non GAAP EPS | 5.51 | 7.29 | 6.85 | 8.68 | 4.72 | |||
| Statistics | ||||||||
| Gross Profit Margin | 95.91% | 95.42% | 98.63% | 100.00% | 100.00% | |||
| Profit Margin | 29.99% | 36.44% | 26.42% | 37.59% | 35.13% | |||
| Operating Profit Margin | 33.50% | 32.89% | 32.30% | 43.47% | 35.08% | |||
All data in DKK